ArticleAnnals of the Royal College of Surgeons of England2026
Impact of postoperative weight loss on anticoagulant dosing after major lower limb amputation.
Article in Annals of the Royal College of Surgeons of England, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveMajor lower limb amputation is often the final treatment for patients with chronic limb-threatening ischaemia. Postoperative weight loss is a common but under-recognised issue that may affect dosing accuracy for weight-dependent anticoagulants such as low molecular weight heparin (LMWH) and direct oral anticoagulants (DOACs). This study assessed the extent of postoperative weight change and the frequency of anticoagulant dose adjustment in routine practice.
methodsA single-centre retrospective cohort study included patients who underwent above- or below-knee amputation between July 2022 and January 2023. Inclusion criteria were documented pre- and postoperative weights and inpatient prescription of LMWH or DOACs. LMWH was prescribed exclusively as dalteparin and DOAC therapy as edoxaban. Doses were reviewed against British National Formulary weight-based recommendations.
resultsOf 39 patients, 17 met inclusion criteria (median age 69 years; 53% male). Procedures were divided evenly between emergency and elective. The mean postoperative weight loss was 7.5%±2.3% of preoperative body weight. Patients undergoing above-knee amputation lost more weight (mean 8.7kg) than those with below-knee amputation (mean 3.8kg). Two patients (11.8%) required dose adjustments - one on edoxaban after falling below 60kg, and one on dalteparin after dropping from 59.5kg to 55.5kg.
conclusionsMajor amputation is associated with clinically relevant postoperative weight loss, yet anticoagulant dose adjustments were uncommon. Routine postoperative weight monitoring and prompt review of weight-based therapy are recommended to improve dosing accuracy and reduce potential anticoagulation risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.